GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Telcon RF Pharmaceutical Inc (XKRX:200230) » Definitions » Research & Development

Telcon RF Pharmaceutical (XKRX:200230) Research & Development : ₩329 Mil (TTM As of Mar. 2025)


View and export this data going back to 2014. Start your Free Trial

What is Telcon RF Pharmaceutical Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Telcon RF Pharmaceutical's Research & Development for the three months ended in Mar. 2025 was ₩178 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 was ₩329 Mil.


Telcon RF Pharmaceutical Research & Development Historical Data

The historical data trend for Telcon RF Pharmaceutical's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Telcon RF Pharmaceutical Research & Development Chart

Telcon RF Pharmaceutical Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,817.09 1,635.20 1,207.51 733.17 722.94

Telcon RF Pharmaceutical Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 217.41 150.83 - - 178.17

Telcon RF Pharmaceutical Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩329 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Telcon RF Pharmaceutical  (XKRX:200230) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Telcon RF Pharmaceutical Research & Development Related Terms

Thank you for viewing the detailed overview of Telcon RF Pharmaceutical's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Telcon RF Pharmaceutical Business Description

Traded in Other Exchanges
N/A
Address
684, Dongtangiheung-ro, Giheung-gu, Gyeonggi-do, Yongin-si, KOR, 17102
Telcon RF Pharmaceutical Inc manufactures wireless communication equipment. It develops connectors for input and output ports, board-to-board, cable assembly, and board-to-mount used in wireless communication equipment. The company also supplies RF coaxial connectors. The company operates in the RF Division and Pharmaceuticals & Biotechnology segments. The majority of its revenue is generated from Pharmaceuticals & Biotechnology, which produces and sells liquids, tablets, pills, capsules, etc.

Telcon RF Pharmaceutical Headlines

No Headlines